The $247.5 million behind Exa's bet that research sells by the run

A Form D filed 28 September shows Exa Labs sold $247,488,419 of equity to 38 unnamed investors with nothing left to sell. The money funds research priced by the run, against frontier labs that bundle it into subscriptions.

In this storya16zPerplexity
Vincent JiangVincent Jiang · 3 min read
Share
Several dozen Exa employees posed on a blue staircase and balcony inside the company's office
1 / 5Slide 1 of 5
Exa's team, in a photo the company published with its $250 million Series C announcement in May 2026. Photo: Exa

The sale began in May. The paper arrived Monday.

Exa Labs told the Securities and Exchange Commission on 28 September 2026 that it had sold $247,488,419 of equity to 38 investors, with nothing left under the offering 12. The notice dates the first sale to 15 May and carries Chief Executive William Bryk's signature of 25 September; the filing is the disclosure, not a stated end to anything 1.

The form prices nothing

It is a Rule 506(b) private sale: no buyer names, no share percentages, revenue range declined, and the SEC warns it has not verified the contents 1. The only people named are officers and directors, Bryk, Jeffrey Wang, Guru Chahal, Peter Fenton and Sarah Wang, over a prior name of Metaphor Systems 2. A price exists only in the company's own 20 May post, which announced a $250 million Series C at a $2.2 billion valuation led by a16z, a company-claimed figure 3.

Three notices, twelve times the money

This is Exa's third Form D in 19 months, and the sold amount has grown twelvefold 45. The March 2025 notice reported $20.6 million fully sold to 66 investors; the March 2026 notice offered $92.0 million, sold $81.4 million to 29 and left $10.6 million unsold 45. The new notice is the largest yet and the first since 2025 to sell every dollar it offered 2. March's round left money on the shelf; this one cleared the book.

Exa's September Form D reports $247.5M fully sold; its last notice left $10.6M unsold

  • Offered
  • Sold
$0M$50M$100M$150M$200M$250MMar 2025 notice$20.59M$20.59M0.0%Mar 2026 notice$81.37M$92.00M-12%Sep 2026 notice$247.49M$247.49M0.0%
Data
OfferedSoldChange
Mar 2025 notice$20.59M$20.59M0.0%
Mar 2026 notice$92.00M$81.37M-11.6%
Sep 2026 notice$247.49M$247.49M0.0%
Amounts as reported in Exa Labs' Rule 506(b) Form D notices on SEC EDGAR, filed 4 March 2025, 11 March 2026 and 28 September 2026. Millions of US dollars; figures as filed, not SEC-verified.2,4,5

Research by the run, graded by the seller

What the money funds launched 25 September: Agent Ultra 6. The mode is metered, defaults to a $20 cap, accepts up to $100 and can run three hours 78; the full pricing ladder and the grader setup were detailed here on 28 September. Ultra's lead over Opus 5.5, GPT-6 Astra and Perplexity Agent rests on a harness Exa built, running rivals' configurations itself where none were published 68. Its Find-All count of 2,451 entities a task against 146 for Opus 5.5 is vendor-reported and unreproduced 8.

The other camp sells flat rates

The rivals in that table bundle deep research into subscriptions, the opposite bet. If research becomes a checkbox in a plan, metered runs lose their pricing power; the 38 buyers are betting it does not.

Funded on paper, unmarked in price

Superhuman bought the meeting notetaker Fathom on 14 September, terms undisclosed 9; the agent-context layer is transacting at prices nobody prints. For holders of private AI-application exposure, this notice is the only public evidence the premium tier is still funded, and it arrives without a mark: no valuation, no buyers, no revenue range 1. Watch for an amendment to the notice, an independent grading of WANDR, and a frontier lab answering with bundled Ultra-class research or another per-query price cut. Until one lands, the only number anyone has filed about the buyers is a headcount: 38.

How this brief was made

Become a contributor

Reporting on the business of AI and want it read? We take pitches from outside contributors who bring primary sources and a number worth arguing about.

Share

Deepdive

AI-generated from this story and its cited sources. Not investment advice.

Reader comments

0 comments

    Sign up

    Get your curated digest

    After email confirmation, you will receive a daily digest of the most relevant news that matter to your portfolio